Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
China Heparin Industry Report, 2013-2015

China heparin API market: Largest producer and exporter of heparin


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-03-28 22:33:02 - China Heparin Industry Report, 2013-2015 - a new market research report on companiesandmarkets.com

Since the small intestines of pigs (raw materials for production of heparin) in China are abundant (the pig slaughtering volume in China approximates 50% of globe´s total) and heparin APIs are gradually recognized internationally, China has grown into the largest heparin API producing and exporting country around the globe.

Nevertheless, due to the stagnant demand in European and American markets in recent two years and the improved standards for heparin export, the export volume and value of heparin APIs in China both presented a decline trend during 2011-2012. In 2012, the export volume of heparin APIs in China only registered 103.86 tons (with a year-on-year decline of 1.3%), or about 14.5 trillion units (based on 140IU/mg), addressing 46.5% of global heparin

 

 

API demand in corresponding period.

Hepalink, Nanjing King-friend, Dongcheng Biochemicals and Qianhong Bio-pharma are major suppliers of heparin API around the globe. With output and sales volume of heparin API above trillion units in recent years, the four enterprises have been the largest exporters of heparin in China for consecutive years, and shared over 70% of China´s total export of heparin.

Although leading heparin enterprises have had the plans of capacity expansion and heparin industrial chain improvement in previous years, affected by sluggish market demand, enhanced technical standards and other factors, a number of heparin API projects originally planned to start production in 2012 or 2013 were postponed successively, such as the 5T/A project of Hepalink, 2.8T/A project of Dongcheng Bio-chemicals, 4T/A unfractionated heparin sodium and 1.2T/A low-molecular-weight heparin sodium project of Nanjing King-friend. The API project of Qianhong Bio-pharma was completed at the end of 2012, but has not been put into production yet.

Nevertheless, from the perspective of projects proposed and under construction, it is predicted that the newly added capacity of heparin API in China will exceed 23 trillion units by 2015, and the total capacity in China will meet 80% of globe´s total demand.

Along with the increasing of heparin API deliverability, the competitiveness of heparin preparation products in China is also strengthened gradually. Taking the low-molecular-weight heparin calcium market as an example, the market share of GlaxoSmithKline´s Nadroparin in China was 61.0% in 2008, but the figure declined to 52.5% in 2011, and was estimated to decline to 40% or so in 2012. Nevertheless, the low-molecular-weight heparin calcium of Changshan Biochemical has become the first product in China that can compete with the overseas big brands. The revenue of the product only registered RMB86.93 million in 2011, and climbed up to RMB289.6 million in 2012.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com